Skip to Main Content

Headlines

Headline Title

Pediatric Psycho-Oncology Professionals
Marieke de Ruiter

First Name: Marieke

Last Name: de Ruiter

Position Title: PhD Student

Job Responsibilities: Research

Education/Training: Psychology

About Me/My interests: After my master Clinical Neuropsychology at the VU university, I started working as a PhD student at the Emma Childrens Hospital in Amsterdam. The project I work on is called Pediatric Research on Improving Speed, Memory and Attenion (PRISMA) and is focused on neurofeedback in children (8-18 yrs, N = 82) who have been treated for a brain tumor and suffer neuropsychological deficits as a consequence. With the double blind, randomized controlled trial we compare the efficacy of neurofeedback training to placebo training in improving the functioning of these children. At baseline we enrolled N = 43 healthy siblings (8-18 yrs) as a control group to compare baseline functioning of the patients to healthy controls. We are currently analyzing the baseline data of the patients compared to the siblings. The data collection will we completed in October 2013 and we will hopefully be able to present the first results of the intervention soon after data completion.

Training Opportunities: No

My Contact Information:
Address: Meibergdreef 9 (room A3-241), 1105 AZ Amsterdam, the Netherlands
Phone: +31 20 5668226
Email: m.a.deruiter@amc.nl

Topics of Interest for Collaboration: Pediatric oncology, brain tumors, neuropsychology, neurofeedback

Publications that may be of interest to others:  

de Ruiter MA, Mourik R, Schouten-Van Meeteren AYN, Grootenhuis MA, Oosterlaan J.Neurocognitive consequences of pediatric brain tumor and its treatment: a meta-analysis.Developmental medicine & child neurology, 2012.

de Ruiter MA, Schouten-Van Meeteren AYN, van Mourik R , Janssen TWP, Greidanus JEM, Oosterlaan J, Grootenhuis MA. (dec 2012).Neurofeedback to improve neurocognitive functioning of children treated for a brain tumor: design of a double blind randomized controlled trial.BMC Cancer, 2012;12(1), 581.


Dashed Line

return to the top

This Page Last Reviewed on March 12, 2013